Open Access

Thymoma appearing 9 years after the resection of squamous cell carcinoma of the lip: A case report of triple primary tumors and literature review

  • Authors:
    • Nobuyuki Maruyama
    • Takanobu Sasaki
    • Akira Arasaki
    • Akiko Matsuzaki
    • Toshiyuki Nakasone
    • Takao Teruya
    • Akira Matayoshi
    • Tessho Maruyama
    • Kennosuke Karube
    • Jiro Fujita
    • Naoki Yoshimi
    • Yukio Kuniyoshi
    • Kazuhide Nishihara
  • View Affiliations

  • Published online on: July 26, 2019     https://doi.org/10.3892/ol.2019.10675
  • Pages: 2777-2788
  • Copyright: © Maruyama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The occurrence of second primary tumor (SPT)following malignancy treatment is common. In patients with head and neck (H&N) cancer, SPTs principally occur in the H&N region, lungs or esophagus. Therefore, patient follow‑up after cancer treatment is important in order to detect recurrence, metastasis and new primary tumors. However, no standard guidelines on lifelong follow‑up imaging are available. Herein, we report a patient who presented with three metachronous primary tumors‑squamous cell carcinoma (SCC) of the tongue, SCC of the lip and type A thymoma. The third tumor was incidentally detected during follow‑up using contrast‑enhanced computed tomography (CT) 9 years following resection of the second tumor. To the best of our knowledge, this specific combination of metachronous tumors has not yet been reported. Based on the literature review, we observed that thymoma occurs following H&N cancer treatment. Therefore, to ensure that the presence of subsequent thymomas is not overlooked, we suggest regular lifelong follow‑up using contrast‑enhanced CT in patients who had previously been diagnosed with H&N cancer. The literature review revealed that thymomas occur in patients with H&N cancer and should be detected at the earliest convenience.

References

1 

Ko HH, Cheng SL, Lee JJ, Chen HM, Wang CW, Cheng SJ and Kok SH: Factors influencing the incidence and prognosis of second primary tumors in patients with oral squamous cell carcinoma. Head Neck. 38:1459–1466. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Morris LG, Sikora AG, Hayes RB, Patel SG and Ganly I: Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 22:671–679. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Brands MT, Brennan PA, Verbeek ALM, Merkx MAW and Geurts SME: Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature. Eur J Surg Oncol. 44:559–565. 2018. View Article : Google Scholar : PubMed/NCBI

4 

Mehra R, Seiwert TY, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H, et al: Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012. Br J Cancer. 119:153–159. 2018. View Article : Google Scholar : PubMed/NCBI

5 

National Comprehensive Cancer Network: Head and Neck Cancers Version 2, 2018. simplehttps://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdfOctober 22–2018

6 

Sobin LH and Wittekind C: International Union against cancer: TNM Classification of Malignant Tumours. 6th. Wiley-Liss; New York, NY: 2002

7 

Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G, Molinari R and Cantù G: Primary chemotherapy in resectable oral cavity squamous cell cancer: A randomized controlled trial. J Clin Oncol. 21:327–333. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Yamamoto E, Kohama G, Sunakawa H, Iwai M and Hiratsuka H: Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 51:2175–2180. 1983. View Article : Google Scholar : PubMed/NCBI

9 

Moertel CG, Dockerty MB and Baggenstoss AH: Multiple primary malignant neoplasms. I. Introduction and presentation of data. Cancer. 14:221–230. 1961. View Article : Google Scholar : PubMed/NCBI

10 

Warren S and Gates O: Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer. 16:13581932.

11 

Cooper A: The Anatomy of the Thymus Gland. Longman; London, Rees, Orme, Green, and Brown, London: 1832

12 

Kamata T, Yoshida S, Wada H, Fujiwara T, Suzuki H, Nakajima T, Iwata T, Nakatani Y and Yoshino I: Extrathymic malignancies associated with thymoma: A forty-year experience at a single institution. Interact Cardiovasc Thorac Surg. 24:576–581. 2017.PubMed/NCBI

13 

Souadjian JV, Silverstein MN and Titus JL: Thymoma and cancer. Cancer. 22:1221–1225. 1968. View Article : Google Scholar : PubMed/NCBI

14 

Lattes R: Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer. 15:1224–1260. 1962. View Article : Google Scholar

15 

LeGolvan DP and Abell MR: Thymomas. Cancer. 39:2142–2157. 1977. View Article : Google Scholar : PubMed/NCBI

16 

Donaldson JO, Grunnet ML and Thompson HG: Concurrence of myasthenia gravis, thymoma, and thyroid carcinoma. Arch Neurol. 40:122–124. 1983. View Article : Google Scholar : PubMed/NCBI

17 

Nemoto K, Ishikawa H, Ohnishi Y, Nakamura T and Ohsaki N: Hodgkin's disease accompanied with thymoma. Acta Pathol Jpn. 37:1505–1512. 1987.PubMed/NCBI

18 

Rothberg MS, Eisenbud L and Griboff S: Chronic mucocutaneous candidiasis-thymoma syndrome. A case report. Oral Surg Oral Med Oral Pathol. 68:411–413. 1989. View Article : Google Scholar : PubMed/NCBI

19 

Couture MM and Mountain CF: Thymoma. Semin Surg Oncol. 6:110–114. 1990. View Article : Google Scholar : PubMed/NCBI

20 

Senga O, Hikita H, Kinoshita T, Hara K and Miyakawa M: Myasthenia gravis with thymoma associated with occult thyroid carcinoma. Surg Today. 22:66–68. 1992. View Article : Google Scholar : PubMed/NCBI

21 

Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, Ginsberg RJ, Martini N, McCormack PM, Rusch V, et al: Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg. 60:908–913. 1995. View Article : Google Scholar : PubMed/NCBI

22 

Reiner B, Siegel E, Sawyer R, Brocato RM, Maroney M and Hooper F: The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck. AJR Am J Roentgenol. 169:667–671. 1997. View Article : Google Scholar : PubMed/NCBI

23 

Perez E, Barnadas MA, Garcia-Patos V, Pedro C, Curell R, Sander CA, Kind P, de Moragas JM and Alomar A: Kaposi's sarcoma in a patient with erythroblastopenia and thymoma: Reactivation after topical corticosteroids. Dermatology. 197:264–267. 1998. View Article : Google Scholar : PubMed/NCBI

24 

Wilkins KB, Sheikh E, Green R, Patel M, George S, Takano M, Diener-West M, Welsh J, Howard S, Askin F and Bulkley GB: Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg. 230:562–572. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Pan CC, Chen PC, Wang LS, Chi KH and Chiang H: Thymoma is associated with an increased risk of second malignancy. Cancer. 92:2406–2411. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Evoli A, Minisci C, Di Schino C, Marsili F, Punzi C, Batocchi AP, Tonali PA, Doglietto GB, Granone P, Trodella L, et al: Thymoma in patients with MG-Characteristics and long-term outcome. Neurology. 59:1844–1850. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Welsh JS, Thurman SA and Howard SP: Thymoma and multiple malignancies: A case of five synchronous neoplasms and literature review. Clin Med Res. 1:227–232. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Engels EA and Pfeiffer RM: Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 105:546–551. 2003. View Article : Google Scholar : PubMed/NCBI

29 

Evoli A, Punzi C, Marsili F, Di Schino C, Cesario A, Galetta D, Margaritora S and Granone P: Extrathymic malignancies in patients with thymoma. Ann Oncol. 15:692–693. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Omu O, Ozcan Z, Yazici B, Akgun A, Oral A and Ozkilic H: Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome. Endocr J. 55:365–372. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Yen YT, Lai WW, Wu MH, Lin MY, Chang JM, Hsu IL and Tseng YL: Thymic neuroendocrine carcinoma and thymoma are both associated with increased risk of extrathymic malignancy: A 20-year review of a single institution. Ann Thorac Surg. 91:219–225. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Doumasa S, Ioannis A, Voutsadakisbd, Fourkasc N, Papagiannic M and Papandreou CN: Concomitant thymic carcinoma with cervical and supraclavicular node metastases and thyroid carcinoma: Report of a case and literature review. J Med Cases. 3:181–184. 2012.

33 

Anzai T, Yokoyama J, Ohba S, Ito S, Fujimaki M, Kojima M and Ikeda K: An important initial diagnosis of a patient with Graves' disease associated with myasthenia gravis, thyroid carcinoma, and thymoma. Head Neck Oncol. 4:562012.

34 

Ni H and Htet A: Follicular thyroid carcinoma in a patient with myasthenia gravis and thymoma: A rare association. Ecancermedicalscience. 6:2742012.PubMed/NCBI

35 

Thongprayoon C, Tantrachoti P, Phatharacharukul P, Buranapraditkun S and Klaewsongkram J: Associated immunological disorders and cellular immune dysfunction in thymoma: A study of 87 cases from Thailand. Arch Immunol Ther Exp (Warsz). 61:85–93. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Filosso PL, Galassi C, Ruffini E, Margaritora S, Bertolaccini L, Casadio C, Anile M and Venuta F: Thymoma and the increased risk of developing extrathymic malignancies: A multicentre study. Eur J Cardiothorac Surg. 44:219–224. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Filosso PL, Venuta F, Oliaro A, Ruffini E, Rendina EA, Margaritora S, Casadio C, Terzi A, Rena O, Lococo F and Guerrera F: Thymoma and inter-relationships between clinical variables: A multicentre study in 537 patients. Eur J Cardiothorac Surg. 45:1020–1027. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Bano G, Sennik D, Kenchaiah M, Kyaw Y, Snape K, Tripathi V, Wilson P, Vlahos I, Hunt I and Hodgson S: A case of co-existing paraganglioma and thymoma. Springerplus. 4:6322015. View Article : Google Scholar : PubMed/NCBI

39 

Karino F, Yokose T, Matsukuma S, Miyagi Y, Murakami S, Ito H, Nakayama H and Yamada K: Clonality analysis performed using human androgen receptor assay in a rare case of undifferentiated thymic carcinoma coexisting with type AB thymoma. Pathol Int. 66:398–403. 2016. View Article : Google Scholar : PubMed/NCBI

40 

Vaziri M and Rad K: Synchronous thymoma and oligodendroglioma: A rare association. Int J Surg Case Rep. 21:95–98. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Hamaji M, Kawaguchi A, Omasa M, Nakagawa T, Sumitomo R, Huang CL, Fujinaga T, Ikeda M, Shoji T, Katakura H, et al: Low incidence of and mortality from a second malignancy after resection of thymic carcinoma. Interact Cardiovasc Thorac Surg. 28:375–379. 2018. View Article : Google Scholar

42 

Mariano C, Ionescu DN, Cheung WY, Ali RH, Laskin J, Evans K, Carolan H and Murray N: Thymoma: A population-based study of the management and outcomes for the province of British Columbia. J Thorac Oncol. 8:109–117. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Johnson SB, Eng TY, Giaccone G and Thomas CR Jr: Thymoma: Update for the new millenium. The Oncologist. 6:239–246. 2001. View Article : Google Scholar : PubMed/NCBI

44 

Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H and Masaoka A: The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: A clinical study of 273 patients. Cancer. 94:624–632. 2002. View Article : Google Scholar : PubMed/NCBI

45 

Okumura M, Shiono H, Minami M, Inoue M, Utsumi T, Kadota Y and Sawa Y: Clinical and pathological aspects of thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 56:10–16. 2008. View Article : Google Scholar : PubMed/NCBI

46 

Hosaka Y, Tsuchida M, Umezu H, Eimoto T, Hashimoto T, Shinohara H and Hayashi J: Primary thymic adenocarcinoma coexisting with type AB thymoma: A rare case with long-term survival. Gen Thorac Cardiovasc Surg. 58:488–491. 2010. View Article : Google Scholar : PubMed/NCBI

47 

Hsu NY, Lin JW, Hsieh MJ, Lai YF, Kao CL and Chang JP: Thymic lymphoepithelioma-like carcinoma associated with thymoma in a patient with ocular myasthenia. Scand Cardiovasc J. 32:105–107. 1998. View Article : Google Scholar : PubMed/NCBI

48 

Suster S and Moran CA: Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol. 20:1469–1480. 1996. View Article : Google Scholar : PubMed/NCBI

49 

Kuo TT and Chan JK: Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am J Surg Pathol. 22:1474–1481. 1998. View Article : Google Scholar : PubMed/NCBI

50 

Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Lauriola L and Fattorossi A: Paraneoplastic diseases associated with thymoma. J Neurol. 254:756–762. 2007. View Article : Google Scholar : PubMed/NCBI

51 

Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D and Coloni GF: Thymoma and thymic carcinoma. Gen Thorac Cardiovasc Surg. 60:1–12. 2012. View Article : Google Scholar : PubMed/NCBI

52 

Gong L, Zhang P, Liu XY and Fang M: A rare thymoma case with seven paraneoplastic syndromes. Int J Clin Exp Med. 8:19517–19523. 2015.PubMed/NCBI

53 

Qiao J, Zhou G, Ding Y, Zhu D and Fang H: Multiple paraneoplastic syndromes: Myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma. J Neurol Sci. 308:177–179. 2011. View Article : Google Scholar : PubMed/NCBI

54 

Engels EA: Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 5 (Suppl 4):S260–S265. 2010. View Article : Google Scholar : PubMed/NCBI

55 

Jeong DY, Lee KS, Chung MJ, Zo JI, Shim YM and Moon JW: JOURNAL CLUB: Doubling time of thymic epithelial tumors correlates with world health organization histopathologic classification. AJR Am J Roentgenol. 209:W202–W210. 2017. View Article : Google Scholar : PubMed/NCBI

56 

Weksler B, Nason KS, Mackey D, Gallagher A and Pennathur A: Thymomas and extrathymic cancers. Ann Thorac Surg. 93:884–888. 2012. View Article : Google Scholar : PubMed/NCBI

57 

Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA and Fraumeni JF Jr: New malignancies among cancer survivors: SEER Cancer Registries, 1973–2000. National Cancer Institute. NIH Publ. No 05-5302; Bethesda, MD: 2006, simplehttps://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdfMarch 17–2019

58 

Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Bjorkholm M, Landgren O and Giaccone G: A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer. 128:2688–2694. 2011. View Article : Google Scholar : PubMed/NCBI

59 

Travis LB, Boice JD Jr and Travis WD: Second primary cancers after thymoma. Int J Cancer. 107:868–870. 2003. View Article : Google Scholar : PubMed/NCBI

60 

Welsh JS, Wilkins KB, Green R, Bulkley G, Askin F, Diener-West M and Howard SP: Association between thymoma and second neoplasms. JAMA. 283:1142–1143. 2000. View Article : Google Scholar : PubMed/NCBI

61 

Granato F, Ambrosio MR, Spina D, Lazzi S, Rocca BJ, Voltolini L, Bongiolatti S, Luzzi L, Gotti G, Leoncini L and Tosi P: Patients with thymomas have an increased risk of developing additional malignancies: Lack of immunological surveillance? Histopathology. 60:437–442. 2012. View Article : Google Scholar : PubMed/NCBI

62 

Basta I, Pekmezovic T, Peric S, Nikolic A, Rakocevic-Stojanovic V, Stevic Z, Marjanovic I and Lavrnic D: Extrathymic malignancies in a defined cohort of patients with myasthenia gravis. J Neurol Sci. 346:80–84. 2014. View Article : Google Scholar : PubMed/NCBI

63 

Maruyama T, Nakasone T, Maruyama N, Matayoshi A and Arasaki A: Synchronous quadruple multiple primary cancers of the tongue, bilateral breasts, and kidney in a female patient with a disease-free survival time of more than 5 years: A case report. World J Surg Oncol. 13:2632015. View Article : Google Scholar : PubMed/NCBI

64 

Babacan NA, Aksoy S, Cetin B, Ozdemir NY, Benekli M, Uyeturk U, Ali Kaplan M, Kos T, Karaca H, Oksuzoglu B, et al: Multiple primary malignant neoplasms: Multi-center results from Turkey. J BUON. 17:770–775. 2012.PubMed/NCBI

65 

Martin OA, Yin X, Forrester HB, Sprung CN and Martin RF: Potential strategies to ameliorate risk of radiotherapy-induced second malignant neoplasms. Semin Cancer Biol. 37-38:65–76. 2016. View Article : Google Scholar : PubMed/NCBI

66 

Kotnis A, Namkung J, Kannan S, Jayakrupakar N, Park T, Sarin R and Mulherkar R: Multiple pathway-based genetic variations associated with tobacco related multiple primary neoplasms. PLoS One. 7:e300132012. View Article : Google Scholar : PubMed/NCBI

67 

Hung CY, Ueng SH, Lin YC and Chou WC: Metastatic carcinoma of the urinary bladder in a 67-year-old female with underlying triple primary cancers. Journal of Cancer Research and Practice. 3:49–53. 2016. View Article : Google Scholar

68 

Forrest J, Slaney G, Crocker J, Hallam J and Taylor AM: Multiple malignancy with a familial tendency. Clin Oncol. 7:357–364. 1981.PubMed/NCBI

69 

Travi WD, Brambilla E, Burke AP, Marx A and Nicholson AG: WHO classification of tumours of the lung, pleura, thymus and heart. IARC Press; Lyon, France: 7. 4th. 2015

70 

Motegi S, Uchiyama A, Yamada K, Toki S, Amano H and Ishikawa O: Lichen planus complicated with thymoma: Report of three Japanese cases and review of the published work. J Dermatol. 42:1072–1077. 2015. View Article : Google Scholar : PubMed/NCBI

71 

Mou H, Liao Q, Hou X, Chen T and Zhu Y: Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: Analysis of the surveillance, epidemiology, and end results (SEER) registry (1988–2013). Int J Radiat Biol. 94:495–502. 2018. View Article : Google Scholar : PubMed/NCBI

72 

Hamaji M, Sozu T, Machida R, Omasa M, Menju T, Aoyama A, Sato T, Chen-Yoshikawa TF, Sonobe M and Date H: Second malignancy versus recurrence after complete resection of thymoma. Asian Cardiovasc Thorac Ann. 26:290–295. 2018. View Article : Google Scholar : PubMed/NCBI

73 

Scorsetti M, Leo F, Trama A, D'Angelillo R, Serpico D, Macerelli M, Zucali P, Gatta G and Garassino MC: Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 99:332–350. 2016. View Article : Google Scholar : PubMed/NCBI

74 

Huang J, Detterbeck FC, Wang Z and Loehrer PJ Sr: Standard outcome measures for thymic malignancies. J Thorac Oncol. 5:2017–2023. 2010. View Article : Google Scholar : PubMed/NCBI

75 

Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S, Nakahara K and Fujii Y: Thymectomy and malignancy. Eur J Cardiothorac Surg. 8:251–253. 1994. View Article : Google Scholar : PubMed/NCBI

76 

Owe JF, Cvancarova M, Romi F and Gilhus NE: Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci. 290:66–69. 2010. View Article : Google Scholar : PubMed/NCBI

77 

Szolkowska M, Langfort R, Winiarski S, Zaremba J, Prochorec-Sobieszek M, Rymkiewicz G, Jaskiewicz P and Kowalski DM: Two neoplasms rich in small lymphocytes, B1B2 thymoma and small lymphocytic lymphoma, intermingled in one tumor mass. A case report. Pol J Pathol. 68:75–81. 2017. View Article : Google Scholar : PubMed/NCBI

78 

Rose BS, Jeong JH, Nath SK, Lu SM and Mell LK: Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 29:3503–3509. 2011. View Article : Google Scholar : PubMed/NCBI

79 

Yamashita T, Araki K, Tomifuji M, Tanaka Y, Harada E, Suzuki T, Miyamoto S and Shiotani A: Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer. Asia Pac J Clin Oncol. 13:172–178. 2017. View Article : Google Scholar : PubMed/NCBI

80 

Bunbanjerdsuk S, Vorasan N, Saethang T, Pongrujikorn T, Pangpunyakulchai D, Mongkonsiri N, Arsa L, Thokanit N, Pongsapich W, Anekpuritanang T, et al: Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma. Mod Pathol. Feb 8–2019.(Epub ahead of print). doi: 10.1038/s41379-019-0211-2. View Article : Google Scholar : PubMed/NCBI

81 

da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA and Kowalski LP: Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis. 32:55–63. 2015. View Article : Google Scholar : PubMed/NCBI

82 

Sun Y, Yu W, Sturgis EM, Peng W, Lei D, Wei Q, Song X and Li G: Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. BMC Cancer. 16:702016. View Article : Google Scholar : PubMed/NCBI

83 

Zhou S, Lu Z, Wu H, Gu CY, Zhang DY, Sun WL, Ma X and Liu HC: Synchronous multiple primary gallbladder and gastric malignancies: Report of two cases and review of the literature. Mol Clin Oncol. 7:869–873. 2017.PubMed/NCBI

84 

Guy GP Jr, Yabroff KR, Ekwueme DU, Smith AW, Dowling EC, Rechis R, Nutt S and Richardson LC: Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood). 33:1024–1031. 2014. View Article : Google Scholar : PubMed/NCBI

85 

Choi J, Lee M, Ki M, Lee JY, Song YJ, Kim M, Lee S, Park S and Lim J: Risk factors for feelings of sadness and suicide attempts among cancer survivors in South Korea: Findings from nationwide cross-sectional study (KNHANES IV–VI). BMJ Open. 7:e0161302017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Maruyama, N., Sasaki, T., Arasaki, A., Matsuzaki, A., Nakasone, T., Teruya, T. ... Nishihara, K. (2019). Thymoma appearing 9 years after the resection of squamous cell carcinoma of the lip: A case report of triple primary tumors and literature review. Oncology Letters, 18, 2777-2788. https://doi.org/10.3892/ol.2019.10675
MLA
Maruyama, N., Sasaki, T., Arasaki, A., Matsuzaki, A., Nakasone, T., Teruya, T., Matayoshi, A., Maruyama, T., Karube, K., Fujita, J., Yoshimi, N., Kuniyoshi, Y., Nishihara, K."Thymoma appearing 9 years after the resection of squamous cell carcinoma of the lip: A case report of triple primary tumors and literature review". Oncology Letters 18.3 (2019): 2777-2788.
Chicago
Maruyama, N., Sasaki, T., Arasaki, A., Matsuzaki, A., Nakasone, T., Teruya, T., Matayoshi, A., Maruyama, T., Karube, K., Fujita, J., Yoshimi, N., Kuniyoshi, Y., Nishihara, K."Thymoma appearing 9 years after the resection of squamous cell carcinoma of the lip: A case report of triple primary tumors and literature review". Oncology Letters 18, no. 3 (2019): 2777-2788. https://doi.org/10.3892/ol.2019.10675